Tag: Myelofibrosis

Jakafi (ruxolitinib) is metabolized by the cytochrome P450 (CYP3A4) enzyme; this process can be disrupted by certain foods. Understanding what foods should you avoid while taking Jakafi is crucial to prevent dangerous drug interactions and ensure the medication's safety and effectiveness.

Affecting approximately 4 to 6 people per 100,000 in the United States, Myelofibrosis (MF) is a rare but serious blood cancer. Understanding what is MF in health is crucial for recognizing the condition and pursuing appropriate medical guidance. This disorder, characterized by scarring of the bone marrow, can lead to numerous health complications if left unmonitored.